Resection of glioma-Feeding the beast?
作者信息
Blobner Jens, Tonn Joerg-Christian
机构信息
Department of Neurosurgery, LMU University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
German Cancer Consortium (DKTK), partner site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
出版信息
Neuro Oncol. 2022 Jul 1;24(7):1088-1089. doi: 10.1093/neuonc/noac078.
Abstract
摘要
相似文献
1
Resection of glioma-Feeding the beast?胶质瘤切除术——喂养这头猛兽？
Neuro Oncol. 2022 Jul 1;24(7):1088-1089. doi: 10.1093/neuonc/noac078.
2
Radiosurgery for brain tumours: is there a proven benefit?脑肿瘤的放射外科治疗：是否存在已证实的益处？
Br J Neurosurg. 1995 Apr;9(2):123-5. doi: 10.1080/02688699550041449.
3
The microsurgery of brain tumours.脑肿瘤的显微外科手术。
Adv Ophthalmol. 1978;37:188-92.
4
Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults.成人使用个人染发剂与患胶质瘤、脑膜瘤和听神经瘤的风险
Am J Epidemiol. 2007 Jan 1;165(1):63-71. doi: 10.1093/aje/kwk002. Epub 2006 Nov 1.
5
Using machine learning to predict health-related quality of life outcomes in patients with low grade glioma, meningioma, and acoustic neuroma.利用机器学习预测低级别胶质瘤、脑膜瘤和听神经瘤患者的健康相关生活质量结局。
PLoS One. 2022 May 4;17(5):e0267931. doi: 10.1371/journal.pone.0267931. eCollection 2022.
6
Oncopolitics: where does the neurosurgeon fit in the management of brain cancer?肿瘤政治学：神经外科医生在脑癌治疗中扮演何种角色？
Clin Neurosurg. 2008;55:35-46.
7
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.DNA 修复基因多态性与成人脑膜瘤、神经胶质瘤和听神经瘤的风险。
Neuro Oncol. 2010 Jan;12(1):37-48. doi: 10.1093/neuonc/nop012. Epub 2009 Dec 10.
8
[Current problems concerning the indications for surgical approach to the internal auditory canal in some otoneurological diseases].[某些耳神经科疾病中内耳道手术入路指征的当前问题]
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol. 1980 Apr-Jun;25(2):81-9.
9
Surgery for brain tumours--present limits.脑肿瘤手术——当前的局限
Australas Radiol. 1985 May;29(2):105-7. doi: 10.1111/j.1440-1673.1985.tb01671.x.
10
Radiosurgery for brain tumours.脑肿瘤的放射外科治疗
Eur J Cancer. 1991;27(12):1545-8. doi: 10.1016/0277-5379(91)90411-6.
引用本文的文献
1
Unraveling the intricacies of glioblastoma progression and recurrence: insights into the role of NFYB and oxidative phosphorylation at the single-cell level.解析胶质母细胞瘤进展和复发的复杂性：在单细胞水平上深入了解 NFYB 和氧化磷酸化的作用。
Front Immunol. 2024 Mar 6;15:1368685. doi: 10.3389/fimmu.2024.1368685. eCollection 2024.
2
Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults.免疫疗法在成人复发性胶质母细胞瘤中的临床应用
Cancers (Basel). 2023 Jul 31;15(15):3901. doi: 10.3390/cancers15153901.
3
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.分子诊断在复发性胶质瘤治疗决策中的意义
Neurooncol Adv. 2023 May 12;5(1):vdad060. doi: 10.1093/noajnl/vdad060. eCollection 2023 Jan-Dec.
4
Maximal safe resection of diffuse lower grade gliomas primarily within central lobe using cortical/subcortical direct electrical stimulation under awake craniotomy.在清醒开颅手术中，主要在中央叶内使用皮质/皮质下直接电刺激对弥漫性低级别胶质瘤进行最大安全切除。
Front Oncol. 2023 Feb 21;13:1089139. doi: 10.3389/fonc.2023.1089139. eCollection 2023.
5
TSPO PET signal using [F]GE180 is associated with survival in recurrent gliomas.TSPO PET 信号使用 [F]GE180 与复发性脑胶质瘤的生存相关。
Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):859-869. doi: 10.1007/s00259-022-06006-1. Epub 2022 Nov 4.
本文引用的文献
1
Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.手术切除胶质母细胞瘤会在复发性肿瘤中诱导多效蛋白介导的胶质母细胞瘤干细胞自我更新。
Neuro Oncol. 2022 Jul 1;24(7):1074-1087. doi: 10.1093/neuonc/noab302.
2
Evidence-based recommendations on categories for extent of resection in diffuse glioma.弥漫性胶质瘤切除范围分类的循证医学建议。
Eur J Cancer. 2021 May;149:23-33. doi: 10.1016/j.ejca.2021.03.002. Epub 2021 Apr 2.
3
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma.肿瘤细胞在神经胶质瘤关键微环境龛中的可塑性、异质性和耐药性。
Nat Commun. 2021 Feb 12;12(1):1014. doi: 10.1038/s41467-021-21117-3.
4
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.胶质母细胞瘤免疫治疗的独特挑战-癌症免疫学领域的神经肿瘤学和非神经肿瘤学专家的讨论。2019 年 SNO 免疫肿瘤学智囊团会议报告。
Neuro Oncol. 2021 Mar 25;23(3):356-375. doi: 10.1093/neuonc/noaa277.
5
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.EANO 成人弥漫性胶质瘤诊断与治疗指南。
Nat Rev Clin Oncol. 2021 Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8.
6
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.胶质母细胞瘤中的干细胞相关异质性源自受微环境影响的固有肿瘤可塑性。
Nat Commun. 2019 Apr 16;10(1):1787. doi: 10.1038/s41467-019-09853-z.
7
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.新辅助抗 PD-1 免疫治疗在复发性胶质母细胞瘤中促进了肿瘤内和全身免疫应答，并带来生存获益。
Nat Med. 2019 Mar;25(3):477-486. doi: 10.1038/s41591-018-0337-7. Epub 2019 Feb 11.
8
Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications.复发性胶质母细胞瘤微环境中的辐射诱导改变：治疗意义
Front Oncol. 2018 Nov 8;8:503. doi: 10.3389/fonc.2018.00503. eCollection 2018.
9
Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.肿瘤相关的小胶质细胞/巨噬细胞预测高级别神经胶质瘤预后不良，并与侵袭性肿瘤亚型相关。
Neuropathol Appl Neurobiol. 2018 Feb;44(2):185-206. doi: 10.1111/nan.12428. Epub 2017 Sep 5.
10
Brain tumour cells interconnect to a functional and resistant network.脑肿瘤细胞相互连接形成功能和耐药的网络。
Nature. 2015 Dec 3;528(7580):93-8. doi: 10.1038/nature16071. Epub 2015 Nov 4.
Zotero 插件